Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL

● Ribavirin is an antiviral agent (a guanosine analogue / nucleoside analogue) that inhibits the in vitro growth of several viruses, includi

Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL product packaging
Ophthalmic

Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL

● Ribavirin is an antiviral agent (a guanosine analogue / nucleoside analogue) that inhibits the in vitro growth of several viruses, including respiratory syncytial virus, influenza virus, hepatitis A virus and adenovirus; its mechanism is not fully understood [1][2]
● After entering infected cells, ribavirin is rapidly phosphorylated; the metabolites act as competitive inhibitors of viral synthetic enzymes — inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanylyltransferase — reducing intracellular guanosine triphosphate and impairing viral RNA and protein synthesis, thereby suppressing viral replication and spread [1][2]
● It does not alter viral adsorption, entry or uncoating, and does not induce interferon production [1][2]
● Clear, colourless sterile ophthalmic solution, ribavirin 0.5% (5 mg/mL), in 0.4 mL single-dose units [1][2][3]

Product NameRibavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL
Dosage FormOphthalmic
Strength0.5% (5 mg/mL)
StandardsBP / ENTERPRISE
PackingCustomized per market requirement (bottle / blister / box)
DocumentsCOA, COPP, DMF, CTD Dossiers
MOQContact us for MOQ and current stock
Request Quotation › ← Back to Ophthalmic
WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾
● Herpes simplex virus keratitis [1][2]
💧Administration▾
● For topical ocular use only; instil into the eyelid (conjunctival sac) of the affected eye [1][2][3] ● The product is not intended for other viral eye diseases [1][2] ● Use the ophthalmic preparation within 4 weeks of first opening (Chinese registered PI) [1] ● Manufacturer storage for the 0.5% line: keep at 15–25 °C, protected from light, container tightly closed, do not freeze; discard within 4 weeks of first opening [3]
⚖️Dosage▾
The schedule below refers to registered ribavirin eye-drop products; for the single-dose presentation, instil the volume and frequency prescribed in the approved label of the product concerned [1][2].
⚠️Precautions & Warnings▾
● Contraindicated in patients with hypersensitivity to ribavirin and in pregnancy; breast-feeding women should suspend nursing during use; use is not recommended in the elderly [1][2] ● The product is not intended for other viral eye diseases [1][2] ● Long-term or high-dose use may produce adverse reactions similar to those of systemic use, such as abnormalities of liver function and the blood picture [1][2] ● Use with caution in patients with severe anaemia or hepatic impairment [1][2] ● High-dose use may produce drug interactions similar to systemic use; antagonism with zidovudine has been described, as ribavirin inhibits the conversion of zidovudine to its active phosphorylated form [1][2] ● Paediatric use: no reliable references are available (Chinese registered PI); elderly patients: use not recommended [1][2] ● Adverse reactions: occasional mild local irritation after instillation [1][2] ● Storage: registered PI — keep sealed in a cool place (not above 20 °C), shelf life 24 months [1]; 39 Drugs reference — protect from light and keep tightly closed [2]; manufacturer — store at 15–25 °C, protected from light, do not freeze, discard within 4 weeks of first opening [3] For full prescribing information, refer to the approved product label / Summary of Product Characteristics of the product concerned [1][2][3].

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL — Frequently Asked Questions

Which documents are provided for Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL registration?

Every batch of Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL?

MOQ and lead time for Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL, subject to the regulatory requirements of the destination market.

Which markets have you exported ophthalmic products to?

We have supplied ophthalmic products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL controlled?

Ribavirin Eye Drops 0.5% (5 mg/mL) 0.4 mL is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›
✎ 💬 ↑
👋 Hi! I'm Care, your product guide. Tap me to ask about our medicines & APIs. ×
Care - product guide assistant